Stifel Positive on Alto Neuroscience (ANRO), PT $10, 'risk/reward here for the stock is favorable'
Tweet Send to a Friend
Stifel analyst Paul Matteis reiterated a Buy rating and $10.00 price target on Alto Neuroscience (NYSE: ANRO)The analyst comments "Trading ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
